| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $397,981,843 ) (Continued on the next page) |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01DK139956 | Palmitoylation and Diabetes | 000 | 1 | NIH | 6/25/2026 | $537,032 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01MH138528 | Requirements for ZNF292 in cortical development and mechanisms of pathogenesis in neurodevelopmental disorders | 000 | 1 | NIH | 6/25/2026 | $763,894 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R13AR087810 | ORS/ISFR 19th Biennial Meeting (Orthopaedic Research Society/International Section for Fracture Repair) | 000 | 1 | NIH | 5/4/2026 | $15,000 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | F30AI197461 | The Role of Type I Interferon in Murine Roseolovirus Induced Autoimmune Gastritis | 002 | 1 | NIH | 4/24/2026 | $576 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | F30AI197461 | The Role of Type I Interferon in Murine Roseolovirus Induced Autoimmune Gastritis | 001 | 1 | NIH | 4/10/2026 | $0 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | F30AI197461 | The Role of Type I Interferon in Murine Roseolovirus Induced Autoimmune Gastritis | 000 | 1 | NIH | 4/1/2026 | $36,673 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | S10OD040315 | SPECT/CT for Translational Theranostics Research | 000 | 1 | NIH | 5/5/2026 | $750,000 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R24ES035954 | Maintenance and Enrichment of the Maternal and Developmental Risks from Environmental and Social Stressors (MADRES) Cohort | 000 | 2 | NIH | 2/10/2026 | $280,288 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | F31DA065440 | Investigating the role of locus coeruleus mu opioid receptors in fentanyl drug seeking | 002 | 1 | NIH | 3/25/2026 | $576 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | F31DA065440 | Investigating the role of locus coeruleus mu opioid receptors in fentanyl drug seeking | 001 | 1 | NIH | 2/3/2026 | $0 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | F31DA065440 | Investigating the role of locus coeruleus mu opioid receptors in fentanyl drug seeking | 000 | 1 | NIH | 2/3/2026 | $38,763 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R03DK145778 | Novel Use of Fomepizole in Hepatic Ischemia Reperfusion Injury | 000 | 1 | NIH | 2/4/2026 | $116,625 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01CA303248 | Utilizing integrin-targeted PET imaging and therapeutics to predict and treat radiation-induced pulmonary fibrosis | 000 | 1 | NIH | 6/19/2026 | $645,414 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | K01EB039415 | AI-powered Gradient Echo Plural Contrast Imaging (AI-GEPCI) MRI for Early Detection and Monitoring in Multiple Sclerosis | 000 | 1 | NIH | 6/19/2026 | $119,818 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01CA315474 | Communication and Hospice Online with Optimal Support and Engagement (CHOOSE) | 000 | 1 | NIH | 6/19/2026 | $656,181 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R21AG091159 | Targeting Intramuscular Adipose Quality in Aging | 000 | 1 | NIH | 2/4/2026 | $427,625 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R21AI200336 | A broad host-range Acinetobacter baumannii phage and its novel glycan receptor | 000 | 1 | NIH | 6/16/2026 | $427,625 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | F31DK146720 | Determining Uropathogenic Escherichia coli Fitness Factors in Different Gut Niches | 002 | 1 | NIH | 3/30/2026 | $576 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | K08GM164635 | Investigating the Role of Proton-Sensing G Protein Coupled Receptors in Trauma and Hemorrhagic Shock | 000 | 1 | NIH | 5/14/2026 | $200,613 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | F31DK146720 | Determining Uropathogenic Escherichia coli Fitness Factors in Different Gut Niches | 001 | 1 | NIH | 2/26/2026 | $0 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | F31DK146720 | Determining Uropathogenic Escherichia coli Fitness Factors in Different Gut Niches | 000 | 1 | NIH | 2/26/2026 | $36,673 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R21AI198155 | Identification of Host Factors that Mediate the Nuclear Retention of Unspliced and Partially Spliced HIV-1 Transcripts | 000 | 1 | NIH | 4/1/2026 | $427,626 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R21CA313766 | Harnessing TLR4 Signaling Pathways in CAR Dendritic Cells to Overcome Tumor Immune Tolerance | 000 | 1 | NIH | 5/14/2026 | $399,829 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R13HD122400 | Membrane Excitability and Reproductive Biology | 000 | 1 | NIH | 5/1/2026 | $20,000 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | F31AI197561 | Heightened cholesterol efflux by lymph node macrophages facilitates their transfer of large lymph-borne antigen to resident dendritic cells | 000 | 1 | NIH | 4/1/2026 | $36,673 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01MH136091 | Establishing Specificity and Scalability of Motor Imitation Assessments for Autism Spectrum Disorder | 000 | 1 | NIH | 5/5/2026 | $811,412 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01HL182099 | Investigating the roles for sphingolipid biosynthesis during lung infection | 000 | 1 | NIH | 6/10/2026 | $680,379 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01AG082030 | Deep-Learning-Augmented Quantitative Gradient Recalled Echo (DLA-qGRE) MRI for in vivo Clinical Evaluation of Brain Microstructural Neurodegeneration in Alzheimer Disease | 000 | 2 | NIH | 3/3/2026 | $661,985 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R21TR006271 | A Modular Biomanufacturing and Cryopreservation Platform for Scalable Production of Clinical-Grade Stem Cell Therapies | 000 | 1 | NIH | 4/29/2026 | $427,625 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | F30MH143481 | Investigating the Feasibility of Gene Therapy for the Treatment of TBRS | 001 | 1 | NIH | 2/16/2026 | $0 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | F30MH143481 | Investigating the Feasibility of Gene Therapy for the Treatment of TBRS | 000 | 1 | NIH | 2/16/2026 | $36,673 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R03CA308660 | Risk-Based Prostate Cancer Screening: Perceptions and Informational Needs of Screening-Eligible Men | 000 | 1 | NIH | 4/24/2026 | $160,093 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01HD119277 | Modeling Human Trophoblast Differentiation and Function Using Pluripotent Stem Cells | 000 | 2 | NIH | 6/16/2026 | $645,137 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | K01MD020519 | A Precision Medicine Approach to Fetal Growth Restriction Among Black Women | 000 | 2 | NIH | 3/27/2026 | $134,404 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01CA307529 | Lung Cancer Care and Prognosis: Medicare Advantage vs Traditional Medicare | 000 | 1 | NIH | 4/17/2026 | $425,088 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01DK143569 | Brown adipose tissue derived nidogen-2 as a diabetes therapeutic | 000 | 1 | NIH | 1/26/2026 | $578,846 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R21CA313180 | Exploiting ADAR1-regulated serine metabolism for cancer therapy | 000 | 1 | NIH | 6/30/2026 | $399,829 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | S10OD038349 | Abberior MIRAVA STED Microscope | 000 | 1 | NIH | 5/12/2026 | $750,000 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01AG095248 | A fiber implant for long-term, deep-brain imaging and manipulation in mouse models of Alzheimer disease | 001 | 1 | NIH | 1/14/2026 | $0 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01CA311209 | Clinical Translation of the First Meitner-Auger PET Theranostic | 000 | 1 | NIH | 5/11/2026 | $641,419 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01AG095248 | A fiber implant for long-term, deep-brain imaging and manipulation in mouse models of Alzheimer disease | 000 | 1 | NIH | 12/30/2025 | $683,028 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01DA063124 | A Multiomic Single Nucleus RNA-seq and ATAC-seq Examination of Key Brainstem Respiratory Control Regions from Fentanyl Overdose Decedents with and without Xylazine Present, and Matched Controls | 000 | 1 | NIH | 3/12/2026 | $577,531 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01DK144822 | Understanding Phosphatidylserine (PS) as a Signaling Moiety during Differentiation | 000 | 1 | NIH | 5/12/2026 | $610,628 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | K02DA065836 | Implementation speed and scale-up of personalized tobacco use treatment | 000 | 1 | NIH | 5/7/2026 | $144,372 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R21AG098547 | Age Differences in the Acquisition and Retention of Flexible Navigation Behaviors | 000 | 1 | NIH | 1/23/2026 | $427,625 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | U24CA321205 | WashU Somatic Mosaicism across Human Tissues (SMaHT) Program Organizational Center | 000 | 4 | NIH | 6/30/2026 | $2,981,460 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | K99AG090693 | Epigenetic modulations by sleep to mitigate neurodegeneration | 000 | 2 | NIH | 6/25/2026 | $124,797 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01CA298938 | Radiation-guided antibody-drug conjugates for cancer therapy | 000 | 1 | NIH | 3/30/2026 | $542,644 |
| | 2026 | 2026 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01GM163062 | Real-Time Software-Hardware Integration for Dynamic Control of Tissue Mechanical Environments | 000 | 1 | NIH | 3/31/2026 | $1,244,000 |
|
